BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng C, Chen C, Wu C. Precision Medicine in Cholangiocarcinoma: Past, Present, and Future. Life 2022;12:829. [DOI: 10.3390/life12060829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Roderburg C, Labuhn S, Bednarsch J, Lang SA, Schneider AT, Hammerich L, Vucur M, Ulmer TF, Neumann UP, Luedde T, Loosen SH. Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer. Mediators Inflamm 2022;2022:6195004. [PMID: 36505756 DOI: 10.1155/2022/6195004] [Reference Citation Analysis]
2 Capuozzo M, Santorsola M, Landi L, Granata V, Perri F, Celotto V, Gualillo O, Nasti G, Ottaiano A. Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology. Int J Mol Sci 2022;23. [PMID: 36499450 DOI: 10.3390/ijms232315124] [Reference Citation Analysis]
3 Sandru V, Ungureanu BS, Stan-ilie M, Oprita R, Balan GG, Plotogea O, Rinja E, Butuc A, Panaitescu A, Constantinescu A, Gheonea DI, Constantinescu G. Efficacy of Endobiliary Radiofrequency Ablation in Preserving Survival, Performance Status and Chemotherapy Eligibility of Patients with Unresectable Distal Cholangiocarcinoma: A Case-Control Study. Diagnostics 2022;12:1804. [DOI: 10.3390/diagnostics12081804] [Reference Citation Analysis]